BREAST IMPLANT GLOBAL SETTLEMENT WILL BE RULED ON BY SEPT. 1
This article was originally published in The Gray Sheet
Executive Summary
BREAST IMPLANT GLOBAL SETTLEMENT WILL BE RULED ON BY SEPT. 1 after U.S District Court of Northern Alabama Judge Samuel Pointer considers whether the settlement is fair to women from other countries. After a three-day hearing, held beginning Aug. 18 in Birmingham, Pointer said Aug. 23 that he will issue a ruling by Sept. 1 on whether the silicone implant settlement is "fair, reasonable, adequate, and in the best interests of class members." Final approval of the class action case appears likely, but Pointer said that while he considers the $4.25 bil. settlement to be in the best interest of the American litigants, the question of fairness to foreign claimants caused him to delay his ruling.
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.